FDA Inspection
Chongqing Carelife Pharmaceutical Co., Ltd.Chongqing Carelife Pharmaceutical Co., Ltd. – FDA Inspection, Mar 28, 2025
Record Details
This FDA Inspection record concerns Chongqing Carelife Pharmaceutical Co., Ltd., with an inspection on March 28, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- March 28, 2025
- Product Type
- Human Drugs
View Company Profile
ID · bfcbabfa-de5d-4c24-aac2-5520177340a0
Inspection Facts
- Inspection number
- 1268964
- FDA center
- Human Drugs
Other FDA inspections of Chongqing Carelife Pharmaceutical Co., Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 19, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 30, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 19, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 18, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 30, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chongqing Carelife Pharmaceutical Co., Ltd.
- FDA Inspection 1098996 - 2019-07-19
- FDA Inspection 1035442 - 2017-11-30
- FDA Inspection 970028 - 2016-05-19
- FDA Inspection 851858 - 2013-10-18
- FDA Inspection 684797 - 2010-07-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.